Rain Therapeutics Inc. (RAIN)
$0.99
$-0.02
(-2.47%)
As on 28-Aug-2026 13:33EDT
Market cap
$10 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-57.2
-
Face value
--
-
Shares outstanding
11,646,299
5 Years Aggregate
CFO
$-188.83 Mln
EBITDA
$-160.19 Mln
Net Profit
$-229.26 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Rain Therapeutics (RAIN)
| -83.1 | -24.5 | -60.0 | -71.7 | -1.2 | -43.9 | -- |
|
BSE Sensex
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
|---|---|---|
|
Rain Therapeutics (RAIN)
| -85.0 | -37.9 |
|
S&P Small-Cap 600
| 13.9 | -17.4 |
|
BSE Sensex
| 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Rain Therapeutics (RAIN)
|
1.0 | 9.9 | 0.0 | -11.8 | -62,993.2 | -- | -- | 0.0 |
| 84.9 | 12,304.7 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.4 | |
| 246.7 | 16,614.0 | 1,054.4 | 755.9 | 5.7 | -- | 19.4 | 10.1 | |
| 72.3 | 10,682.6 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 54.2 | 13,400.0 | 2,435.9 | 860.6 | 31.0 | 43 | 17 | 7.3 | |
| 105.3 | 12,277.1 | 1,663.7 | 413.6 | 36.3 | 430 | 31.2 | 83.9 | |
| 350.5 | 10,258.4 | 440.5 | 241.5 | 33.4 | 18.7 | 42.2 | 7.3 | |
| 534.5 | 11,938.8 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 22.9 | |
| 603.9 | 17,326.2 | 2,782.3 | 491.5 | 21.1 | 110.1 | 36.5 | 39.4 | |
| 348.4 | 10,496.2 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 |
Shareholding Pattern
View DetailsAbout Rain Therapeutics (RAIN)
Rain Enhancement Technologies Holdco, Inc. develops, improves, and commercializes atmospheric enhancement by ionization (AEI) technology. It plans to develop improvements on existing rainfall generation technologies by introducing robust measurement... tools, including software monitoring technology, machine learning, rain gauges, and weather stations. The company was founded in 2022 and is headquartered in Naples, Florida. Read more
-
Co-Founder, CEO & Chairman
Mr. Avanish Vellanki M.B.A.
-
Co-Founder, CEO & Chairman
Mr. Avanish Vellanki M.B.A.
-
Headquarters
Naples, FL
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Rain Therapeutics (RAIN)
What is the current share price of Rain Therapeutics Inc (RAIN) Today?
The share price of Rain Therapeutics Inc (RAIN) is $0.99 (NASDAQ) as of 28-Aug-2026 13:33 EDT. Rain Therapeutics Inc (RAIN) has given a return of -1.16% in the last 3 years.
What is the current PB & PE ratio of Rain Therapeutics Inc (RAIN)?
Since, TTM earnings of Rain Therapeutics Inc (RAIN) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-5.26 |
-3.75 |
2024 |
-- |
-- |
2023 |
-18.84 |
-12.93 |
2022 |
-0.57 |
-201.44 |
2021 |
12.95 |
0.41 |
What is the 52 Week High and Low of Rain Therapeutics Inc (RAIN)?
The 52-week high and low of Rain Therapeutics Inc (RAIN) are Rs 8.50 and Rs 0.81 as of 29-Aug-2026.
What is the market cap of Rain Therapeutics Inc (RAIN)?
Rain Therapeutics Inc (RAIN) has a market capitalisation of $ 10 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Rain Therapeutics Inc (RAIN)?
Before investing in Rain Therapeutics Inc (RAIN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.